Smartphone-Operated, Single-Lead ECG Performs As Well As 12L-Device in Side-by-Side Study
Can atrial fibrillation and atrial flutter be accurately detected using a smartphone-operated single-lead electrocardiography device?
Diagnosis & Disease Information
Secondhand Smoke Exposure in Childhood Increases Atrial Fibrillation Risk
Researchers sought to determine whether parental smoking is a risk factor for atrial fibrillation among offspring by evaluating data on offspring cohort participants who had known smoking parents in the original cohort of the multigenerational Framingham Heart Study.
Liver Disease History Does Not Alter Efficacy and Safety of Edoxaban in AF
A history of mild liver disease is associated with a higher risk for bleeding during anticoagulation therapy but does not change the relative efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation.
Incident Atrial Fibrillation Linked to Increased Dementia Risk
Oral anticoagulant use has preventive effect on dementia development in patients with incident AF.
Risk Factors Identified for Atrial Fibrillation With Type 1 Diabetes
Risk factors for developing atrial fibrillation similar to those seen for other forms of cardiovascular disease.
Factors Associated With Bleeding Events in Anticoagulated Patients With Afib
Attending to modifiable risk factors is an important treatment target in patients with atrial fibrillation treated with anticoagulants to reduce thromboembolic and bleeding events.
Case Clinic: A 67-Year-Old White Male Patient With Atrial Fibrillation Risk Factors
Detecting previously undiagnosed, asymptomatic AF may help to prevent future thromboembolic events and the onset of symptoms, and may reduce AF-related morbidity and hospitalizations.
Societies Release Updated Guidelines for the Management of Atrial Fibrillation
In order to revise the guidelines, the Task Force reviewed clinical trials presented at the annual scientific meetings of the ACC, AHA, HRS, and European Society of Cardiology in addition to other peer-reviewed, published data.
Apixaban in Patients With ESRD and Atrial Fibrillation
There are limited published data on the efficacy and safety of direct-acting oral anticoagulants (DOACs) in patients with end-stage renal disease (ESRD) on dialysis and atrial fibrillation.
NOACs Recommended as First-Line Prevention of Stroke in AF
Updated guidelines also emphasize weight loss for overweight, obese patients with atrial fibrillation.
- Loading...
Loading...
Next post in Cardiovascular Disease Information Center
Loading... 
Loading...